CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We are very excited to launch our new website! Please take a few moments to click around and explore...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...